designer491/iStock via Getty Images STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover speculation. The maker of implantable lenses is said to have been approached by larger rival Alcon (ALC), according to a StreetInsider report on Wednesday, which cited an unidentified source. It’s not clear if the approach will lead toContinue Reading
Dmitry Vinogradov Glaukos Corporation (NYSE:GKOS) traded lower on Wednesday after Citi downgraded the glaucoma product maker to neutral from buy as part of a review of its U.S. MedTech coverage ahead of Q2 2024 results. Analyst Joanne Wuensch argued that Glaukos (GKOS), which has climbed more than 50% this year,Continue Reading
Sundry Photography 10x Genomics (NASDAQ:TXG) stock slid 14% Wednesday amid news that Illumina (ILMN) has acquired single cell analysis technology company Fluent BioSciences and a downgrade by Deutsche Bank. The investment bank cut its rating of 10x Genomics to hold, stating that heightened competition was “eroding the inelastic demand thatContinue Reading
Tonpor Kasa Kazia Therapeutics (NASDAQ:KZIA) stock soared 142% in morning trading Wednesday after the company reported positive Phase 2/3 results for its drug paxalisib in the treatment of glioblastoma. A primary analysis of the study, called GBM-AGILE, showed a median overall survival of 14.77 months for paxalisib treated patients versusContinue Reading
KanawatTH Shares of digital media company Ziff Davis (NASDAQ:ZD) slumped as much as 12.3% on Wednesday after the company disclosed in a Securities and Exchange filing that its second quarter results will come in below average Wall Street analyst estimates. The company said that the participants of its convertible notesContinue Reading
LaraBelova Mizuho Securities called out Boyd Gaming (NYSE:BYD) and Red Rock Resorts (NASDAQ:RRR) as intriguing picks in the casino sector ahead of the Q2 earnings season. Analyst Ben Chaiken thinks trends are sequentially improving for both casino operators. The firm updates Q2 earnings estimates for both RRR and BYD andContinue Reading
JHVEPhoto Longeveron (NASDAQ:LGVN) shares climbed in the morning hours Wednesday after the U.S. FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation for its lead asset Lomecel-B as a treatment for mild Alzheimer’s. Targeted at regenerative medicines, including cell therapies such as Lomecel-B, the RMAT designation offers regulatory benefits similar toContinue Reading
samxmeg Stock futures were mixed early on Wednesday after Fed Chair Jerome Powell emphasized in his testimony that more positive inflation data is needed before considering rate cuts. Market participants eagerly awaited his second round of testimony. Here are some of Wednesday’s biggest stock movers: Biggest stock gainers Baidu’s (NASDAQ:BIDU)Continue Reading
Kevin Frayer Baidu’s (NASDAQ:BIDU) stock jumped about 10% in Hong Kong on Wednesday after Beijing authorities said on Tuesday that they will support the introduction of robotaxis in ride hailing and car rental fleets in the city, Bloomberg News reported. In China, Baidu’s operates robotaxi Apollo Go, whose sixth generationContinue Reading
moxiecreative Ahead of the CEO Investor Summit, Aehr Test Systems (NASDAQ:AEHR) stock was up 14.3% in premarket trade on Wednesday after it reported preliminary financial results for its fourth quarter and fiscal year 2024 and said that its FY24 revenue and net income exceed its previously provided guidance. For itsContinue Reading
